chartexchange

Immatics Announces Third Quarter 2026 Financial Results and Business Update

GlobeNewswire Inc. | Nov 10, 2026 7:00 AM EST

Houston, Texas and Tuebingen, Germany, November 10, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today provided a business update and reported financial results for the quarter ended September 30, 2026.

Read original article